Central Drugs Standard Control Organization
GPTKB entity
Statements (63)
Predicate | Object |
---|---|
gptkbp:instanceOf |
regulatory authority
|
gptkbp:approves |
new drugs
|
gptkbp:collaboratesWith |
gptkb:World_Health_Organization
academic institutions |
gptkbp:conducts |
research studies
public awareness campaigns inspections stakeholder consultations post-marketing surveillance |
gptkbp:coordinatesWith |
state drug authorities
|
gptkbp:develops |
regulatory policies
national drug policy |
gptkbp:ensures |
quality control
transparency in operations drug safety ethical standards in trials |
gptkbp:establishedIn |
1966
|
gptkbp:evaluates |
clinical trial applications
|
gptkbp:facilitates |
research and development
drug distribution drug importation |
https://www.w3.org/2000/01/rdf-schema#label |
Central Drugs Standard Control Organization
|
gptkbp:issues |
annual reports
guidelines safety alerts import licenses drug recalls public advisories guidelines for bioequivalence studies guidelines for drug manufacturing certificates of compliance drug price control orders drug safety guidelines guidelines for adverse event reporting |
gptkbp:locatedIn |
gptkb:India
|
gptkbp:maintains |
drug database
|
gptkbp:manages |
drug registration process
|
gptkbp:monitors |
adverse drug reactions
pharmaceutical advertising drug quality standards |
gptkbp:operates |
gptkb:Ministry_of_Health_and_Family_Welfare
|
gptkbp:oversees |
clinical trials
|
gptkbp:participatesIn |
international forums
|
gptkbp:promotes |
public health
generic drugs rational use of medicines |
gptkbp:provides |
technical support
training programs consultation services regulatory updates licensing services guidance on clinical trials information on drug recalls |
gptkbp:regulates |
clinical laboratories
medical devices pharmaceutical industry narcotic drugs |
gptkbp:responsibleFor |
drug approval
|
gptkbp:supports |
vaccine development
pharmaceutical education innovation in pharmaceuticals health research. healthcare_initiatives |